综合多组学数据的肝细胞癌分层策略及进展

肝细胞癌（hepatocellular carcinoma,HCC）是最常见和致命的肝脏恶性肿瘤。这种疾病的治疗一直受到其异质性的阻碍,极大限制了其个性化治疗的进展。因此,将高度异质的HCC分成具有相似特征的分子亚类对其临床治疗有着重要意义。随着高通量技术的不断发展,多种组学数据的关联研究可以加深了解HCC发生背后的生物学机制,也为HCC分层研究打开了新的思路。本文对当前HCC多组学分层策略及其相关研究进行了综述,并总结了当前HCC亚型的多组学特征。     

糜子黄、黑种皮遗传及转录组学分析

同源异型域-亮氨酸拉链(homedomain-leucine zipper,HD-Zip)转录因子广泛参与植物的生长发育和抗胁迫过程。该研究通过生物信息学方法对青稞HD-Zip基因家族进行全基因组分析鉴定,并采用qRT-PCR技术分析非生物胁迫下该基因的表达特性,为深入探讨青稞HD-Zip转录因子的生物学功能及其在高原作物抗逆育种中的应用奠定基础。结果表明：(1)成功从青稞基因组中共鉴定出41个HD-Zip基因家族成员,依次命名为i>HvvHD-ZipⅠ-1~Ⅳ-13,且这些基因在7条染色体上呈不均匀分布。(2)理化性质分析发现,HvvHD-Zip蛋白包含197～885个不等的氨基酸残基;分子量范围在19 914.36～94 014.87 Da;亚细胞定位表明HvvHD-Zip蛋白都位于细胞核。(3)根据多序列比对、系统进化、基因结构和保守基序差异将其聚为4个亚家族,各亚家族分类特征与系统聚类结果一致。(4)顺式作用元件预测分析发现,i>HvvHD-Zip基因启动子中含有11种植物激素和胁迫响应元件。(5)qRT-PCR结果显示,HvvHD-Zip Ⅰ、Ⅱ、Ⅳ亚家族基因对各胁迫响应明显;与根组织相比,多数i>HvvHD-Zip基因在叶组织中响应明显(上调或下调);与冷和盐胁迫相比,i>HvvHD-Zip各基因对旱胁迫响应较强。     

Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignant tumours worldwide. Given metabolic reprogramming in tumours was a crucial hallmark, several studies have demonstrated its value in the diagnostics and surveillance of malignant tumours. The present study aimed to identify a cluster of metabolism-related genes to construct a prediction model for the prognosis of HCC. Multiple cohorts of HCC cases (466 cases) from public datasets were included in the present analysis. (GEO cohort) After identifying a list of metabolism-related genes associated with prognosis, a risk score based on metabolism-related genes was formulated via the LASSO-Cox and LASSO-pcvl algorithms. According to the risk score, patients were stratified into low- and high-risk groups, and further analysis and validation were accordingly conducted. The results revealed that high-risk patients had a significantly worse 5-year overall survival (OS) than low-risk patients in the GEO cohort. (30.0% vs. 57.8%; hazard ratio [HR], 0.411; 95% confidence interval [95% CI], 0.302–0.651; p < 0.001) This observation was confirmed in the external TCGA-LIHC cohort. (34.5% vs. 54.4%; HR 0.452; 95% CI, 0.299–0.681; p < 0.001) To promote the predictive ability of the model, risk score, age, gender and tumour stage were integrated into a nomogram. According to the results of receiver operating characteristic curves and decision curves analysis, the nomogram score possessed a superior predictive ability than conventional factors, which indicate that the risk score combined with clinicopathological features was able to achieve a robust prediction for OS and improve the individualized clinical decision making of HCC patients. In conclusion, the metabolic genes related to OS were identified and developed a metabolism-based predictive model for HCC. Through a series of bioinformatics and statistical analyses, the predictive ability of the model was approved.     

Differences between migrasome,a ‘new organelle’, and exosome

The migrasome is a new organelle discovered by Professor Yu Li in 2015. When cells migrate, the membranous organelles that appear at the end of the retraction fibres are migrasomes. With the migration of cells, the retraction fibres which connect migrasomes and cells finally break. The migrasomes detach from the cell and are released into the extracellular space or directly absorbed by the recipient cell. The cytoplasmic contents are first transported to the migrasome and then released from the cell through the migrasome. This release mechanism, which depends on cell migration, is named ‘migracytosis’. The main components of the migrasome are extracellular vesicles after they leave the cell, which are easy to remind people of the current hot topic of exosomes. Exosomes are extracellular vesicles wrapped by the lipid bimolecular layer. With extensive research, exosomes have solved many disease problems. This review summarizes the differences between migrasomes and exosomes in size, composition, property and function, extraction method and regulation mechanism for generation and release. At the same time, it also prospects for the current hotspot of migrasomes, hoping to provide literature support for further research on the generation and release mechanism of migrasomes and their clinical application in the future.     

梅花鹿甲烷能代谢规律的研究

本文应用ＫＢ－１型呼吸测热装置,结合消化、代谢试验,对梅花鹿（Ｃｅｒｖｕｓｎｉｐｐｏｎ）甲烷能代谢规律进行了研究。结果表明,梅花鹿甲烷能的产生量随其采食量的增加而增加;也随着果食后时间的推移而减少,而且减少的幅度又随采食量的增加而下降;甲烷能的产生量分别占总能食入量、消化能食入量和体增热的６．６１％、８．８３％和１０．８８％;甲烷能的产生量随着日粮蛋白质水平的提高而降低,日粮蛋白质水平每提高１个百分点,甲烷能产生量就降低５８．５８ｋＪ／ｄ;分别以总能食入量（ＧＥＩ）和干物质食入量（ＤＭＩ）为自变量所建立的甲烷能（ＣＨ４Ｅ）估计分别为：ＣＨ４Ｅ（ｋＪ／ｄ）＝０．０７ＣＥＪ（ｋＪ／ｄ）－１０１．０４（ｎ＝１２,ｒ＝０．９４４,Ｐ＜０．０１）ＣＨ４Ｅ（ｋＪ／ｄ）＝９８．７８＋１．０５ＤＭＩ（ｇ／ｄ）（ｎ＝１２,ｒ＝０．９４２,Ｐ＜０．０１）     

苜蓿根瘤菌固氮酶基因启动子P1转录起始点下游顺序(DS)的特性

自生状态的苜蓿根瘤菌(Rhizobium meliloti)nifHDK操纵子的启动子P1能被微氧诱导而呈高水平表达,而fixABCX操纵子的启动子P2则呈微弱的表达.P1和 P2的 DNA顺序从转录起始点到上游-160处具有 85％的同源性,但从转录起始点到翻译起始点的核苷酸顺序则完全不同.用P1转录起始点下游从+17到+61核苷酸的DNA片段(DS)取代P2区的相应的DNA顺序,在自生状态微氧诱导条件下能提高P2的表达水平,在大肠杆菌中有NifA存在时P2亦呈高水平表达,说明P1和P2区的DS顺序是决定P1和P2自生状态微氧诱导条件下表达或异源表达差异的根本原因.在共生状态下P2的表达不依赖启动子下游顺序.采用引物延伸法测定 P2的转录起始点,发现 P2区当引入 P1区的 DS后不改变它的转录起始点.由于P2不论有DS的插入与否均不影响其在根瘤菌共生状态的正常表达,因此P2在自生状态的根瘤菌中与共生状态时的表达调节将有所不同.     

远交系小鼠胚胎干细胞系的建立及嵌合鼠的获得

ＥＳ细胞（ＥｍｂｒｙｏｎｉｃＳｔｅｍＣｅｌｌｓ）是来源于小鼠早期胚胎的多潜能干细胞,它可以在体外大量培养。并以单细胞的形式注射到早期胚胎里,发育为嵌合体。到目前为止,通常使用的１２９小鼠品系是来源于近交系（ｉｎｂｒｅｄ）小鼠的胚胎．与之相比,远交系小鼠应当具有较强的生命力和抗病能力。曾有人报道过建成了远交系小鼠胚胎干细胞系,但是尚没有见到获得嵌合鼠的报道。有人甚至认为：由于不同品系小鼠所具有的遗传背景不同,有的小鼠不能建成ＥＳ细胞系。最近,本实验室在这方面做了有益的探索,成功地建成了远交系小鼠胚胎干细胞系,并在这里报导首例用远交系小鼠胚胎干细胞系培育成功嵌合体小鼠。采用源于Ｓｗｉｓｓ小鼠远交群的昆明（ＫＭ）品系小鼠囊胚建成了三个小鼠胚胎干细胞系（ＫＥ１．ＫＥ２．ＫＥ５）。核型正常率均达到７０％以上。自第八代起分批冻存,复苏后,培养至第１２代,消化成单细胞,通过囊胚显微注射,将其注射到６１５品系小鼠胚胎。在幸存的幼鼠中获得了一只来源于ＫＥ１细胞的嵌合鼠（Ｔａｂｌｅ１）．其毛色表现为受体鼠（６１５）的白色中嵌合有供体鼠（ＫＭ）的黑褐色（ＰｌａｔｅＩ－Ａ）．嵌合鼠与受体鼠的杂交后代鼠中仍然出现了受体鼠的毛色类型（     

绞股蓝属的染色体研究

报道了葫芦科绞股蓝属（Ｇｙｎｏｓｔｅｍｍａ Ｂ１．）８种共２０个居群的染色体数目,分别为２ｎ＝２２,３３,４４,６６,８８多倍体现象极为普遍。两个亚属;绞股蓝亚属（Ｓｕｂｇｅｎ．Ｇｙｎｏｓｔｅｍｍａ）和喙果藤亚属（Ｓｕｂｇｅｎ．Ｔｒｉｏｓｔｅｌｌｕｍ）的染色体基数均为Ｘ＝１１,并结合该属植物形态特征、繁殖方式和地理分布,对普遍出现的多倍体现象进行了讨论。